Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03877276 · ClinicalTrials.gov registry record · NA
Dietary Oxalate and Immune Cell Function
A NA study of Kidney Stone, sponsored by University of Alabama at Birmingham.
- Active
- Registry status
- NA
- Development phase
- 82
- Enrollment target
- 1
- Study location
NCT03877276: Active NA study of Kidney Stone, sponsored by University of Alabama at Birmingham.
NCT03877276 is a NA study of Kidney Stone that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 82 participants, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03877276, a NA study of Kidney Stone, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate mitochondrial function in white blood cells and platelets from healthy individuals following dietary oxalate intake.
Primary Outcome
Cellular bioenergetics (oxygen consumption rate) will be measured in isolated monocytes from human blood using a Seahorse XF Analyzer machine. Monocyte cellular bioenergetics will be measured before and after consuming a spinach smoothie (pre- and post-loads; Time 0 hours and 5 hours) to assess a change in monocyte cellular energetics after 5 hours.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Breakfast
- DIETARY_SUPPLEMENT Spinach smoothie
- DIETARY_SUPPLEMENT Kale smoothie
- DIETARY_SUPPLEMENT Blended smoothie
- DIETARY_SUPPLEMENT V spinach smoothie
Study Locations (1)
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2016-07-21 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
What the registry record for NCT03877276 still lists
NCT03877276 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 82 participants, a relatively small participant target, below the 190-participant average among 28 other Kidney Stone trials with a reported enrollment target (57% lower).
The record links to 1 condition, with Kidney Stone appearing as the primary indexed condition, and to 5 interventions - of which Breakfast is the first listed.
NCT03877276 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT03877276 about?
NCT03877276 is a clinical study titled "Dietary Oxalate and Immune Cell Function". The purpose of this study is to evaluate mitochondrial function in white blood cells and platelets from healthy individuals following dietary oxalate intake.
What is the current status of trial NCT03877276?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 82 participants. The study started on 2016-07-21. Estimated completion is 2027-12-01.
What conditions does trial NCT03877276 study?
This clinical trial studies the following conditions: Kidney Stone.
What interventions are being tested in trial NCT03877276?
The interventions under investigation include: Breakfast (DIETARY_SUPPLEMENT), Spinach smoothie (DIETARY_SUPPLEMENT), Kale smoothie (DIETARY_SUPPLEMENT), Blended smoothie (DIETARY_SUPPLEMENT), V spinach smoothie (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03877276?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03877276 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Stone
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03877276's enrollment target sits among peer trials
82 11th of 28 higher than 18 of 28 other Kidney Stone trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Stone trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
Gut Oxalate Absorption in Calcium Oxalate Stone Disease
RECRUITING · NA
-
High Powered Stone Dusting vs. Fragmentation and Basketing at Time of Ureteroscopy
RECRUITING · NA
-
Access Sheath and Stent Trial
RECRUITING · NA
-
GI Oxalate Absorption
RECRUITING · NA
-
Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03319901 · 82 participants · Phase 1
Venetoclax and Chemotherapy as Frontline Therapy in Older Patients and Patients With Relapsed/Refractory ALL
- NCT03493425 · 82 participants · Phase 2
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by Surgery
- NCT04105270 · 82 participants · Phase 2
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- NCT04428658 · 82 participants · NA
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI